Page 28 - Generation Sequencing News Today

Share this article Share this article ResearchAndMarkets.coms offering. The North America life science tools market size is expected to reach USD 81.9 billion by 2027 registering a CAGR of 11.6% The market growth is attributed to a rise in government funding for life science technologies, growth of cell & gene therapies, increasing demand for biopharmaceuticals, and a rise in competition among prominent market entities. Competitive dynamics continue to drive a rapid pace of innovation in seque...

Share this article Share this article ResearchAndMarkets.coms offering. The Global Next-generation Sequencing Market was valued at USD 8206.75 Million in 2019 and is projected to grow at a CAGR of 19.59% during the forecast period. Enhancing regulatory framework for next-generation sequencing based tests for diagnostics is the key factor for the growth of the Global Next-generation Sequencing Market during the forecast period. Moreover, advancements in next-generation sequencing coupled with re...

Dermal Fillers Market Size worth USD 6.64 Billion by 2027 at 9.3% CAGR; High Demand for Minimally Invasive Surgeries to Boost Growth: Fortune Business Insights™ Top Players Covered in the Dermal Fillers market Research Report Are ALLERGAN (Dublin, Ireland), Revance Therapeutics, Inc. (California, U.S.), Merz Pharma (Frankfurt, Germany), Galderma (Lausanne, Switzerland), Sinclair Pharma (London, U.K.), Sun Pharmaceutical Industries Ltd (Mumbai, India), BIOPLUS CO., LTD. (South Kore...

Spatial Genomics and Transcriptomics Market, 2030 News provided by Share this article Share this article ResearchAndMarkets.coms offering. Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030, progressing at a CAGR of 23.20%. The market is driven by certain factors, which include the increasing prevalence of various types of genetic disorders, such as cancer, neurological disorder, and rare diseases, inciting the development of high-resolution multiplex assays a...

A market with fundamental growth factors is impacted by the COVID-19 Pandemic. Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report. the publisher includes a special segment, Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 130 companies are profiled. A range of dynamic tr...

(2) DALLAS, TX / ACCESSWIRE / February 16, 2021 / According to new report added in Report Banana offerings, there are significant money making opportunities available in the bioinformatics market. Companies planning to enter this market need to prepare and differentiate to maximize their return on investment. In terms of opportunities, the bioinformatics market is expected to grow from $7.73 billion in 2018 to USD 13.50 billion in 2023; it is expected to grow at a CAGR of 14.5% during the forec...

Share this article Share this article ResearchAndMarkets.coms offering. Healthcare experts at BIS have found genomic data analysis and interpretation industry to be one of the most rapidly evolving and dynamic markets and the global market for Genomic data analysis and interpretation is predicted to grow at a CAGR of 10.21% over the forecast period of 2020-2030. The market is driven by certain factors, which include decreasing cost of sequencing, global increase in cancer prevalence, and incre...

Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Global Genomic Data Analysis and Interpretation Market: Focus on Products, Genomic Platforms,...

Naija247news.com is an investigative news platform that tracks news on Nigerian Economy, Business, Politics, Financial and Africa and Global Economy.

(1) DUBLIN, Feb. 2, 2021 /PRNewswire/ -- Eurofins is making new assays for the identification of B.1.1.7 (UK) and B.1.351 (South Africa)/B.1.1.248 (Brazil) variants with a one hour run time available for free to public health institutions who do not have capabilities to rapidly identify the presence of these variants. SARS-CoV-2 belongs to a group of RNA viruses that exhibit spontaneous mutations. Some alarming variants have recently been identified including: The new lineage B.1.1.7 first id...